Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute
2019-05-15 20:13
China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results
2019-05-15 18:00
China Biologic Reports Financial Results for the First Quarter of 2019
2019-05-11 04:30
Kazia calls for greater awareness of the deadliest gynecological cancer in the US
2019-05-08 20:00
Samsung BioLogics signs CDO(Contract Development Organization) contract with GI Innovation
2019-05-03 14:36
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
2019-04-30 22:35
China Biologic Products to Report First Quarter 2019 Financial Results
2019-04-30 20:00
GC Pharma Reports Q1 2019 Results
2019-04-30 15:37
Sihuan Pharm's Innovative Digestive System Drug Anaprazole Sodium Achieved Early Completion of Patient Recruitment for Phase II Clinical Trial in China
2019-04-25 21:07
Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?
2019-04-24 16:00
HEC TaiGen Initiates Phase III Trial of Combination of Furaprevir and Yimitasvir for the Treatment of Chronic Hepatitis C Patients in China
2019-04-23 15:58
Collaborative Medicinal Development LLC wins AU$1 million grant award from FightMND
2019-04-18 01:11
China SXT Pharmaceuticals, Inc. Announces Pricing of a $15 Million PIPE Financing
2019-04-17 21:01
GC Pharma Marks 'World Hemophilia Day'
2019-04-16 10:57
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
2019-04-16 07:15
Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition
2019-04-15 20:00
CStone received IND approval in China for avapritinib Phase I/II bridging registrational study in patients with advanced gastrointestinal stromal tumors
2019-04-15 14:32
World First Development of an Arsenic-Peptide to Target Cancer
2019-04-12 14:00
Mallinckrodt's INOmax™ (Nitric Oxide) Gas, for Inhalation, Approved in Australia for Pulmonary Hypertension in Adults in Conjunction with Cardiovascular Surgery
2019-04-11 05:00
Dr Gillies O'Bryan-Tear Joins Clarity Pharmaceuticals' Board
2019-04-10 09:30
1
130
131
132
133
134
165